UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany

Rheumatology (Oxford, England), 2014-05, Vol.53 (5), p.882-889

2014

Volltextzugriff (PDF)

Vasculitis mimics

Zeitschrift für Rheumatologie, 2019-02, Vol.78 (1), p.24-30

2019

Volltextzugriff (PDF)

Vasculitis update

Zeitschrift für Rheumatologie, 2012-11, Vol.71 (9), p.742-742

2012

Volltextzugriff (PDF)

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis

Rheumatology (Oxford, England), 2007-07, Vol.46 (7), p.1087-1091

2007

Volltextzugriff (PDF)

Morbidity and mortality in systemic rheumatoid diseases: how did they change?

Zeitschrift für Rheumatologie, 2011-08, Vol.70 (6), p.462-463

2011

Volltextzugriff (PDF)

No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register

Rheumatology (Oxford, England), 2002-05, Vol.41 (5), p.540-549

2002

Volltextzugriff (PDF)

FRI0230 Stable incidence rates of anca-associated vasculitides and giant cell arteritis in northern germany (schleswig-holstein) from 1998 to 2010

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.392-392

2013

Volltextzugriff (PDF)

Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany

Rheumatology (Oxford, England), 2000-12, Vol.39 (12), p.1396-1402

2000

Volltextzugriff (PDF)

Diagnosis and evaluation of vasculitis

Rheumatology (Oxford, England), 2000-03, Vol.39 (3), p.245-252

2000

Volltextzugriff (PDF)

Cyclophosphamid oral vs. Bolus bei Wegener-Granulomatose und anderen ANCA-assoziierten Vaskulitiden: Pro und Contra

Zeitschrift für Rheumatologie, 2009-06, Vol.68 (4), p.345-348

2009

Volltextzugriff (PDF)

Treatment of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated systemic vasculitis with high‐dose intravenous immunoglobulin

Clinical and experimental immunology, 1995-07, Vol.101 (1), p.2-7

1995

Volltextzugriff (PDF)

Maintenance of remission with leflunomide in Wegener's granulomatosis

Rheumatology (Oxford, England), 2004-03, Vol.43 (3), p.315-320

2004

Volltextzugriff (PDF)

Use of methotrexate in ANCA-associated vasculitides

Clinical and experimental rheumatology, 2010-09, Vol.28 (5 Suppl 61), p.S178

2010

Volltextzugriff (PDF)

Wegener-Granulomatose und mikroskopische Polyangiitis

Zeitschrift für Rheumatologie, 2009-02, Vol.68 (1), p.49-64

2009

Volltextzugriff (PDF)

Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease

QJM : An International Journal of Medicine, 1996, Vol.89 (1), p.15-23

1996

Volltextzugriff (PDF)

Development of morbidity and mortality in ANCA-associated vasculitis

Zeitschrift für Rheumatologie, 2011-08, Vol.70 (6), p.486

2011

Volltextzugriff (PDF)

EULAR recommendations for the care of patients with small and medium-sized vessel vasculitides

Zeitschrift für Rheumatologie, 2008-12, Vol.67 (8), p.704-706

2008

Volltextzugriff (PDF)

How I treat

Zeitschrift für Rheumatologie, 2012-11, Vol.71 (9), p.775-784

2012

Volltextzugriff (PDF)

No seasonal variation in the onset of symptoms of 445 patients with Wegener's granulomatosis

Arthritis and rheumatism, 2008-06, Vol.59 (6), p.904-904

2008

Volltextzugriff (PDF)

Update on granulomatosis with polyangitis (GPA, Wegener's granulomatosis)

Zeitschrift für Rheumatologie, 2012-11, Vol.71 (9), p.745

2012

Volltextzugriff (PDF)

MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener's granulomatosis

European radiology, 1997, Vol.7 (4), p.566-570

1997

Volltextzugriff (PDF)

Development and validation of a disease extent index for Wegener's granulomatosis

Clinical nephrology, 2001-01, Vol.55 (1), p.31

2001

Volltextzugriff (PDF)

Longitudinal effects of structured patient education programs for vasculitis patients

Zeitschrift für Rheumatologie, 2008-05, Vol.67 (3), p.206

2008

Volltextzugriff (PDF)

Schmerzen und Schwellung der Sprunggelenke: Keine Arthritis

Zeitschrift für Rheumatologie, 2007-05, Vol.66 (3), p.255-256

2007

Volltextzugriff (PDF)

Mononeuritis secondary to rheumatoid arthritis responds to etanercept

Rheumatology (Oxford, England), 2000-12, Vol.39 (12), p.1436-1437

2000

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Englisch
(68)
Deutsch
(64)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(85)
Science & Technology
(63)
Life Sciences & Biomedicine
(62)
Rheumatology
(55)
Male
(41)
Middle Aged
(41)
Female
(38)
Adult
(34)
Aged
(29)
Biological And Medical Sciences
(27)
Medical Sciences
(27)
Granulomatosis With Polyangiitis - Drug Therapy
(18)
Wegener's Granulomatosis
(15)
Diagnosis, Differential
(13)
Granulomatosis With Polyangiitis - Diagnosis
(13)
Adolescent
(12)
Immunosuppressive Agents - Therapeutic Use
(12)
Prospective Studies
(12)
Treatment Outcome
(12)
Drug Therapy, Combination
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany

Vasculitis mimics

Vasculitis update

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis

Morbidity and mortality in systemic rheumatoid diseases: how did they change?

No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register

FRI0230 Stable incidence rates of anca-associated vasculitides and giant cell arteritis in northern germany (schleswig-holstein) from 1998 to 2010

Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany

Diagnosis and evaluation of vasculitis

Cyclophosphamid oral vs. Bolus bei Wegener-Granulomatose und anderen ANCA-assoziierten Vaskulitiden: Pro und Contra

Treatment of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated systemic vasculitis with high‐dose intravenous immunoglobulin

Maintenance of remission with leflunomide in Wegener's granulomatosis

Use of methotrexate in ANCA-associated vasculitides

Wegener-Granulomatose und mikroskopische Polyangiitis

Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease

Development of morbidity and mortality in ANCA-associated vasculitis

EULAR recommendations for the care of patients with small and medium-sized vessel vasculitides

How I treat

No seasonal variation in the onset of symptoms of 445 patients with Wegener's granulomatosis

Update on granulomatosis with polyangitis (GPA, Wegener's granulomatosis)

MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener's granulomatosis

Development and validation of a disease extent index for Wegener's granulomatosis

Longitudinal effects of structured patient education programs for vasculitis patients

Schmerzen und Schwellung der Sprunggelenke: Keine Arthritis

Mononeuritis secondary to rheumatoid arthritis responds to etanercept

Suchergebnisse filtern